For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Ischaemic heart disease - Independent medicine & health information for consumers & professionals Ischaemic heart disease
Show health professional infoLatest independent information about ischaemic heart diseaseg, including medicines and non-drug treatments, written and reviewed by experts in Australia.
Ischaemic heart disease is also known as coronary disease, coronary artery disease, CAD, coronary heart disease
and coronary vasospasm.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
Cardiovascular risk calculators |
Tools to help health professionals assess a patient’s cardiovascular risk and treatment benefit. |
Tool - Health Professional | Health Professionals | 2009-03-12 00:00:00 |
Case study 38 report: Management of ischaemic heart disease |
Patient, new to the area, presents with ischaemic heart disease. He has various cardiovascular risk factors and admits to low compliance with his medication. |
Professional activity - Case study report | Health Professionals | 2005-10-01 00:00:00 |
Case study 38: Management of ischaemic heart disease |
Patient, new to the area, presents with a history ischaemic heart disease. He has various cardiovascular risk factors and admits to low compliance with his medication. |
Professional activity - Case study | Health Professionals | 2005-08-01 00:00:00 |
Clinical e-Audit: an effective quality improvement activity to optimise treatment of ischaemic heart disease. Abstract NMS 2008 |
The treatment of ischaemic heart disease (IHD) by GP's in Australia and the effectiveness of Clinical e-Audit. O’Riordan S, Lewis, B, Parsons H, Mackson J, Reeve J. National Medicines Symposium, 14-16 May 2008, Canberra, Australia |
Event - Conference abstract | Health Professionals,Research & Evaluation community | 2008-05-16 00:00:00 |
Articles on ischaemic heart disease drugs from NPS RADAR |
Get independent, accurate, evidence-based info on ischaemic heart disease drugs. Written for doctors, pharmacists & other health professionals. |
Topic overview | Health Professionals | 2009-10-28 00:00:00 |
Ischaemic heart disease |
Accurate, balanced, evidence-based information, resources and educational activities on ischaemic heart disease. Information for health professionals. |
Topic overview | Health Professionals | 2009-09-20 00:00:00 |
Managing my heart health |
Download a Managing my heart health at a glance card. This card helps people with or at risk of cardiovacular disease to track their medical and lifestyle factors, including medicine compliance and daily activity. |
Consumer publication - Brochure | Consumers,Health Professionals | 2011-09-16 00:00:00 |
Lumiracoxib (Prexige) for osteoarthritis |
Since this issue of Medicine Update was published, lumiracoxib (Prexige) has been withdrawn by the Therapeutic Goods Administration. |
Consumer publication - Medicine Update | Consumers | 2007-04-01 00:00:00 |
New clinical e-audits easier to use for GPs |
A clinical audit for optimising drug use in ischaemic heart disease is now available in electronic format, allowing GPs to review the clinical management of their patients more easily. |
Media release | Others | 2007-03-26 00:00:00 |
NPS Prescribing Practice Review 17: Managing dyslipidaemia |
Information on managing dyslipidaemia, including who should be treated with lipid-modifying therapy (i.e. lifestyle and/or drug therapy). Sample feedback prescribing data is also provided. |
Professional publication - Prescribing Practice Review | Health Professionals | 2002-03-05 00:00:00 |
NPS Prescribing Practice Review 31: Ischaemic heart disease |
Information on the multiple medications that are often necessary in the treatment of ischaemic heart disease including aspirin, statins, beta blockers and ACE inhibitors. |
Professional publication - Prescribing Practice Review | Health Professionals | 2005-09-01 00:00:00 |
Hypertension and cardiovascular risk |
Information on managing hypertension as a cardiovascular risk factor including advice on assessing risk, selecting antihypertensives, lifestyle interventions and encouraging patient compliance. |
Professional publication - Prescribing Practice Review | Health Professionals | 2007-07-01 00:00:00 |
Managing lipids - Reducing CVD risk |
Reviews early assessment of cardiovascular risk and consideration of who would benefit from a lipid-lowering drug together with lifestyle changes |
Professional publication - Prescribing Practice Review | Health Professionals | 2011-03-01 00:00:00 |
NPS Prescribing Practice Review 31: Ischaemic heart disease |
Information on the multiple medications that are often necessary in the treatment of ischaemic heart disease including aspirin, statins, beta blockers and ACE inhibitors. |
Professional publication - Prescribing Practice Review | Health Professionals | 2005-09-01 00:00:00 |
Your heart and stroke risk score patient resource |
The Your heart and stroke risk score summary sheet explains absolute cardiovascular risk to patients and includes a space for you to record their risk score. |
Professional tool - Patient leaflet | Health Professionals | 2011-09-21 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2011-03-25 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
